These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36064981)

  • 1. Effect of phytate on crystallization on ureteral stents and bacterial attachment: an in vitro study.
    Calvó P; Mateu-Borras M; Costa-Bauza A; Albertí S; Grases F
    Urolithiasis; 2022 Dec; 50(6):737-742. PubMed ID: 36064981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phytate and pyrophosphate on brushite and hydroxyapatite crystallization. Comparison with the action of other polyphosphates.
    Grases F; Ramis M; Costa-Bauzá A
    Urol Res; 2000 Apr; 28(2):136-40. PubMed ID: 10850638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Phytate (InsP6) and Other Inositol-Phosphates (InsP5, InsP4, InsP3, InsP2) on Crystallization of Calcium Oxalate, Brushite, and Hydroxyapatite.
    Calvó P; Costa-Bauza A; Grases F
    Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: implications for urinary stone pathogenesis.
    Grover PK; Kim DS; Ryall RL
    Mol Med; 2002 Apr; 8(4):200-9. PubMed ID: 12149569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
    Saw NK; Chow K; Rao PN; Kavanagh JP
    J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.
    Grases F; Rodriguez A; Costa-Bauza A
    J Urol; 2015 Sep; 194(3):812-9. PubMed ID: 25818031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticalculus effect of a triclosan mouthwash containing phytate: a double-blind, randomized, three-period crossover trial.
    Grases F; Perelló J; Sanchis P; Isern B; Prieto RM; Costa-Bauzá A; Santiago C; Ferragut ML; Frontera G
    J Periodontal Res; 2009 Oct; 44(5):616-21. PubMed ID: 18973518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the effects of different substances on the early stages of papillary stone formation.
    Grases F; Garcia-Ferragut L; Costa-Bauzá A; March JG
    Nephron; 1996; 73(4):561-8. PubMed ID: 8856252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of oxalocalcic lithiasis: effects of their interactions on calcium oxalate crystallization.
    Muñoz JA; López-Mesas M; Valiente M
    Urology; 2012 Nov; 80(5):1163.e13-8. PubMed ID: 22748613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytate Dephosphorylation Products Also Act as Potent Inhibitors of Calcium Oxalate Crystallization.
    Grases F; Costa-Bauzá A; Calvó P; Julià F; Dietrich J; Gomila RM; Martorell G; Sanchis P
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of trace metals on the inhibition of calcium oxalate crystallization.
    Muñoz JA; Valiente M
    Urol Res; 2005 Aug; 33(4):267-72. PubMed ID: 15937709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation.
    Tang R; Nancollas GH; Giocondi JL; Hoyer JR; Orme CA
    Kidney Int; 2006 Jul; 70(1):71-8. PubMed ID: 16641926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors.
    Costa-Bauzá A; Barceló C; Perelló J; Grases F
    Int Urol Nephrol; 2002; 34(4):447-51. PubMed ID: 14577482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A
    Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid as inducer of calcium oxalate crystal development.
    Grases F; Sanchis P; Isern B; Perelló J; Costa-Bauzá A
    Scand J Urol Nephrol; 2007; 41(1):26-31. PubMed ID: 17366099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary calculi and infection].
    Trinchieri A
    Urologia; 2014; 81(2):93-8. PubMed ID: 24874306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytate acts as an inhibitor in formation of renal calculi.
    Grases F; Isern B; Sanchis P; Perello J; Torres JJ; Costa-Bauza A
    Front Biosci; 2007 Jan; 12():2580-7. PubMed ID: 17127264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.